Meme stocks to look out (BLBX, GME, AMC, NOK, BB, BBY, SPCE)
WallStreetPR · 7h ago
Crypto names among premarket loser on China crackdown
Onconova Therapeutics ONTX -15% on capital raise. MEDIROM Healthcare Technologies (NASDAQ:MRM) -12%. Kintara Therapeutics KTRA -12% on capital raise. Cellect Biotechnology (NASDAQ:APOP) -11%. InnSuites Hospitality Trust (NYSE:IHT) -11%. Arqit Quantum (NASD...
Seekingalpha · 7h ago
22 Stocks Moving in Friday's Pre-Market Session
Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month.
Benzinga · 10h ago
ONTX, RWLK and MRIN among mid-day movers
Gainers: TransCode Therapeutics (NASDAQ:RNAZ) +79%. MEDIROM (NASDAQ:MRM) +77%. ReWalk Robotics Ltd. (NASDAQ:RWLK) +38%. TScan Therapeutics (NASDAQ:TCRX) +29%. AeroCentury (NYSE:ACY) +20%. Transcontinental Realty Investors (NYSE:TCI) +19%. Neonode (NASDAQ:N...
Seekingalpha · 1d ago
Why Are TransCode Therapeutics Shares Shooting Higher On Thursday?
Benzinga · 1d ago
Mid-Morning Market Update: Markets Open Higher; Accenture Profit Beats Views
Following the market opening Thursday, the Dow traded up 1.38% to 34,732.57 while the NASDAQ rose 0.97% to 15,041.00. The S&P also rose, gaining 1.22% to 4,449.12.
Benzinga · 1d ago
DPW, JOBY and CEI among pre market gainers
MEDIROM Healthcare Technologies (NASDAQ:MRM) +77% on deal for ZACC Kabushiki Kaisha Digital Brands (NASDAQ:DBGI) +27%. TransCode Therapeutics (NASDAQ:RNAZ) +15% announces publication in cancer nanotechnology of preclinical data supporting therapeutic poten...
Seekingalpha · 1d ago
BRIEF-Transcode Therapeutics Publishes Preclinical Data On Therapeutic Potential Of TTX-MC138 In Cancer Nanotechnology · 1d ago
TransCode Therapeutics Announces Publication in Cancer Nanotechnology of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Metastatic Breast Cancer
BOSTON, September 23, 2021--TransCode Therapeutics, Inc. (Nasdaq: RNAZ), an emerging RNA oncology company created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics, today announced that prec...
Business Wire · 1d ago
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) rose 48.3% to $0.777 in pre-market trading after gaining over 3% on Monday. The company, earlier during the month, reported downbeat quarterly results.
Benzinga · 08/24 11:06
BRIEF-TransCode Therapeutics Reports Business Progress And Second Quarter 2021 Financial Results · 08/23 20:04
TransCode Therapeutics Swings to Q2 Profit; Shares Surge After-Hours
MT Newswires · 08/23 16:25
BRIEF-Transcode Therapeutics Inc Awarded Funding From National Institutes Of Health · 08/05 12:10
TransCode Therapeutics Awarded Funding from National Institutes of Health (NIH) to Support Clinical Evaluation of TTX-MC138
BOSTON, August 05, 2021--TransCode Therapeutics, Inc. (Nasdaq: RNAZ), a platform company solving the challenge of RNA delivery in oncology, today announced that it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant from the NIH t...
Business Wire · 08/05 11:30
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 07/23 20:50
61 Biggest Movers From Yesterday
Benzinga · 07/22 09:01
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to purchase Chembio's DPP SARS-CoV-2 Antigen tests for delivery during 2021.
Benzinga · 07/21 16:01
Chembio Diagnostics, NeuroMetrix leads healthcare gainers; NeuroBo Pharmaceuticals, Healthcare Services among major losers
Gainers: Chembio Diagnostics CEMI +195%, NeuroMetrix (NURO) +143%, TRxADE HEALTH MEDS +40%, TransCode Therapeutics (RNAZ) +24%, Cassava Sciences (SAVA) +20%.Losers: NeuroBo Pharmaceuticals (NRBO) -19%, Healthcare Services HCSG -11%, Lumos Pharma (LUMO) -12...
Seekingalpha · 07/21 15:01
54 Biggest Movers From Yesterday
Benzinga · 07/20 09:05
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 07/19 16:31
Webull provides a variety of real-time RNAZ stock news. You can receive the latest news about Transcode Therapeutics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About RNAZ
TransCode Therapeutics, Inc. is a ribonucleic acid (RNA) oncology company. The Company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer. TTX-MC138 comprises proprietary iron-oxide nanoparticles and oligonucleotides that specifically target microRNA-10b. The nanoparticles serve as the vehicle to deliver oligonucleotides to metastatic cancer cells. The magnetic properties of these nanoparticles allow for monitoring of their delivery using non-invasive imaging. Its pipeline products also include TTX-siPDL1, TTX-siLIN28b and TTX-RIGA. TTX-siPDL1 is a checkpoint inhibitor targeting programmed cell death protein ligand 1 (PD-L1). TTX-RIGA utilizes its delivery system and is intended to activate the RIG-I signaling pathway to elicit an immune response to eliminate and/or reduce the risk of developing disorders associated with abnormal apoptotic or differentiative processes, by triggering an immune response that targets developing cancer cells.